Issue 11, 2018

The growing role of structural mass spectrometry in the discovery and development of therapeutic antibodies

Abstract

The comprehensive structural characterization of therapeutic antibodies is of critical importance for the successful discovery and development of such biopharmaceuticals, yet poses many challenges to modern measurement science. Mass spectrometry has evolved into a rapid and sensitive tool for assessing the structures, stabilities, and dynamics of such proteins. Here, we review the current state-of-the-art mass spectrometry technologies focusing on the characterization of antibody-based therapeutics. We conclude by discussing the future of structural mass spectrometry, and its role in enabling the biopharmaceutical pipeline.

Graphical abstract: The growing role of structural mass spectrometry in the discovery and development of therapeutic antibodies

Article information

Article type
Critical Review
Submitted
14 Feb 2018
Accepted
27 Apr 2018
First published
30 Apr 2018

Analyst, 2018,143, 2459-2468

Author version available

The growing role of structural mass spectrometry in the discovery and development of therapeutic antibodies

Y. Tian and B. T. Ruotolo, Analyst, 2018, 143, 2459 DOI: 10.1039/C8AN00295A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements